Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Gets Ready To Compete With Its Late-Stage Diabetes Pipeline

Jul 01 2013

Related Content

Merck And Pfizer Make A Late Play For The Diabetes Market

Apr 29 2013

J&J Gains FDA OK For First-In-Class Type 2 Diabetes Drug Invokana

Mar 29 2013

Amylin, Lilly End Exenatide Tie-Up, Marking End To Litigation

Nov 08 2011

Lilly Plays Up Biotech But Major Pipeline Developments Are Long-Term

Dec 15 2008

Related Companies

Eli Lilly and Company

Johnson & Johnson

Boehringer Ingelheim GmbH

Merck & Co., Inc.

Pfizer Inc.

Bristol Myers Squibb Company

Novo Nordisk A/S

Additional Topics

United States Clinical Trials Business Strategies BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window